Abstract
Lung cancer is the leading cause of cancer-related deaths worldwide. Despite advances in systemic therapy and improvements in survival for advanced non-small cell lung carcinoma (NSCLC), brain metastasis (BM) remained an important etiology of morbidity and mortality. This study was designed to analyze the association between the epidermal growth factor receptor (EGFR) mutation status and the incidence of brain metastases (BM) and associated survival.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
